NVIDIA Corporation vs. YD Bio Limited Ordinary Shares
NVIDIA Corporation and YD Bio Limited Ordinary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| NVDA | YDES | |
|---|---|---|
| Market Cap | $5.45 trillion | $301.08 million |
| Revenue (TTM) | $302.97 billion | — |
| Net Income (TTM) | $192.88 billion | — |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| NVDA | YDES | |
|---|---|---|
| P/E Ratio | 28.31 | — |
| Price / Book | 23.80 | — |
| Price / Sales | 17.99 | — |
NVDA and YDES split the valuation factors evenly.
Profitability
| NVDA | YDES | |
|---|---|---|
| Net Margin | 63.66% | — |
| Return on Equity | 84.23% | — |
NVDA and YDES split the profitability factors evenly.
Dividend
| NVDA | YDES | |
|---|---|---|
| Dividend Yield | 0.45% | — |
| Payout Ratio | 12.64 | — |
NVDA and YDES split the dividend factors evenly.
Risk & Sentiment
| NVDA | YDES | |
|---|---|---|
| Short Interest | 0.07% | 0.00% |
YDES leads on 1 of 1 risk & sentiment factors.
Dig deeper: NVDA overview, NVDA financials, YDES overview, YDES financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.